Evidence map›Paper›PMID 15498039›Full record

ArticleClinical and experimental immunology2004

Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse.

E Ling, G Feldman, M Portnoi, R Dagan, K Overweg, F Mulholland, V Chalifa-Caspi, J Wells, Y Mizrachi-Nebenzahl

Open access · bronzeAbstract read
In one paragraph

Article in Clinical and experimental immunology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 184 citations in OpenAlex.

  1. Article
  2. Article
  3. The oxidative stress response ofFrontiers in microbiology · 2023
    Review
  4. Article
  5. Inhibition ofMicrobiology (Reading, England) · 2022
    Article
  6. Article
  7. Review
  8. A Chimera of Th1 Stimulatory Proteins ofBioMed research international · 2021
    Article
  9. Phenotypic Modulation of Biofilm Formation in aFrontiers in microbiology · 2020
    Article
  10. Review
  11. Why Do Intravascular Schistosomes Coat Themselves in Glycolytic Enzymes?BioEssays : news and reviews in molecular, cellular and developmental biology · 2019
    Article
  12. Pneumococcal Vaccines.Microbiology spectrum · 2019
    Review
  13. Heliyon · 2019
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

E LingPediatric Infectious Disease Unit, Soroka University Medical Center and the Department of Microbiology and Immunology, Ben Gurion University of the Negev, Beer Sheva, Israel.
G Feldman
M Portnoi
R Dagan
K Overweg
F Mulholland
V Chalifa-Caspi
J Wells
Y Mizrachi-Nebenzahl
Ben-Gurion University of the Negev · ILQuadram Institute · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Streptococcus pneumoniae is a leading cause of otitis media, sinusitis, pneumonia, bacteraemia and meningitis worldwide. The drawbacks associated with the limited number of various capsular polysaccharides that can be included in the polysaccharide-based vaccines focuses much attention on pneumococcal proteins as vaccine candidates. We extracted an enriched cell wall fraction from S. pneumoniae WU2. Approximately 150 soluble proteins could be identified by 2D gel electrophoresis. The proteins were screened by 2D-Western blotting using sera that were obtained longitudinally from children attending day-care centres at 18, 30 and 42 months of age and sera from healthy adult volunteers. The proteins were further identified using matrix-assisted laser desorption ionization-time of flight mass spectrometry. Seventeen proteins were antigenic in children and adults, of which 13 showed an increasing antibody response with age in all eight children analysed. Two immunogenic proteins, fructose-bisphosphate aldolase (FBA) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and a control protein with known low immunogenicity, heat shock protein 70 (DnaK), were expressed in Escherichia coli, purified and used to immunize mice. Mouse antibodies elicited to the recombinant (r) FBA and rGAPDH were cross-reactive with several genetically unrelated strains of different serotypes and conferred protection to respiratory challenge with virulent pneumococci. In addition, the FBA used in this study (NP_345117) does not have a human ortholog and warrants further investigation as a candidate for a pneumococcal vaccine. In conclusion, the immunoproteomics based approach utilized in the present study appears to be a suitable tool for identification of novel S. pneumoniae vaccine candidates.

Indexed as

AdultAge FactorsAnimalsAntibody FormationAntigens, BacterialBacterial ProteinsCell MembraneChild, PreschoolEscherichia coli ProteinsFemaleFructose-Bisphosphate AldolaseGlyceraldehyde 3-Phosphate Dehydrogenase (NADP+)GlycolysisHSP70 Heat-Shock ProteinsHumansInfantAntigens, BacterialBacterial ProteinsdnaK protein, E coliEscherichia coli ProteinsFructose-Bisphosphate AldolaseGlyceraldehyde 3-Phosphate Dehydrogenase (NADP+)HSP70 Heat-Shock ProteinsMembrane ProteinsRecombinant Proteins

Identifiers

PMID15498039
PMCPMC1809218
OpenAlexW1977949781

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.